BNP Paribas Financial Markets’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.45M Sell
168,023
-336,693
-67% -$8.92M ﹤0.01% 1432
2025
Q1
$12.2M Buy
504,716
+458,015
+981% +$11.1M 0.01% 925
2024
Q4
$1.88M Sell
46,701
-40,011
-46% -$1.61M ﹤0.01% 1701
2024
Q3
$5.49M Sell
86,712
-170,112
-66% -$10.8M ﹤0.01% 980
2024
Q2
$13.6M Buy
256,824
+178,410
+228% +$9.46M 0.01% 672
2024
Q1
$6.43M Sell
78,414
-164,011
-68% -$13.4M 0.01% 919
2023
Q4
$4.51M Sell
242,425
-135,781
-36% -$2.53M 0.01% 1018
2023
Q3
$4.19M Sell
378,206
-195,403
-34% -$2.16M 0.01% 989
2023
Q2
$9.3M Buy
573,609
+331,815
+137% +$5.38M 0.01% 674
2023
Q1
$4.03M Buy
241,794
+192,051
+386% +$3.2M 0.01% 1006
2022
Q4
$468K Buy
49,743
+49,431
+15,843% +$465K ﹤0.01% 1993
2022
Q3
$849 Sell
312
-4,990
-94% -$13.6K ﹤0.01% 3735
2022
Q2
$15.3K Sell
5,302
-4,904
-48% -$14.2K ﹤0.01% 3075
2022
Q1
$30.6K Sell
10,206
-15,693
-61% -$47.1K ﹤0.01% 3087
2021
Q4
$119K Buy
25,899
+8,569
+49% +$39.4K ﹤0.01% 2906
2021
Q3
$109K Buy
17,330
+6,627
+62% +$41.6K ﹤0.01% 2650
2021
Q2
$64.1K Sell
10,703
-23,551
-69% -$141K ﹤0.01% 2585
2021
Q1
$217K Buy
34,254
+25,088
+274% +$159K ﹤0.01% 2460
2020
Q4
$51.6K Sell
9,166
-6,173
-40% -$34.8K ﹤0.01% 2887
2020
Q3
$89.3K Buy
15,339
+5,740
+60% +$33.4K ﹤0.01% 2565
2020
Q2
$69.2K Sell
9,599
-32,251
-77% -$233K ﹤0.01% 2294
2020
Q1
$196K Buy
41,850
+34,131
+442% +$160K ﹤0.01% 2275
2019
Q4
$61.9K Sell
7,719
-2,065
-21% -$16.6K ﹤0.01% 2868
2019
Q3
$67.3K Buy
9,784
+3,093
+46% +$21.3K ﹤0.01% 2705
2019
Q2
$55.5K Sell
6,691
-5,990
-47% -$49.7K ﹤0.01% 2743
2019
Q1
$126K Buy
+12,681
New +$126K ﹤0.01% 2407
2018
Q4
Sell
-1,424
Closed -$24.8K 3718
2018
Q3
$24.8K Hold
1,424
﹤0.01% 2668
2018
Q2
$13.5K Buy
+1,424
New +$13.5K ﹤0.01% 3008